-
May 21, 2013
Roche has one of the best long-term growth profiles in the Big Pharma space
-
May 21, 2013
A big rally has brought Pfizer back to fair value.
-
May 08, 2013
Amgen really needs the pipeline to come through to support this valuation.
-
April 17, 2013
The pharmaceutical industry is under pressure to do more with less. That means it will be farming out many of is ...
-
February 13, 2013
Theravance Inc.'s (THRX) fourth quarter 2012 loss of 33 cents per share was narrower than the Zacks Consensus loss ...
-
February 12, 2013
Cardiome Pharma Corp. (CRME) recently selected privately-held Quintiles for providing lifecycle safety and global ...
-
February 11, 2013
Domestic stock funds garnered a whopping $21 billion in the initial four weeks of 2013, according to Lipper. This ...
-
February 05, 2013
Benchmarks retreated from recent highs following weaker-than-expected factory orders and investor concerns about the ...
-
February 01, 2013
There is no shortage of economic and earnings data this morning, but the focus remains on the labor market with the ...
-
February 01, 2013
Friday, February 1, 2013 There is no shortage of economic and earnings data this morning, but the focus remains ...
-
February 01, 2013
Merck & Co. (MRK) reported fourth quarter 2012 earnings per share (excluding special items) of 83 cents, a couple of ...
-
January 31, 2013
Endocyte Inc. (ECYT) recently announced that its oncology candidate, EC0652, achieved key objectives in a phase 0 ...
-
January 30, 2013
Merck & Co. Inc. (MRK) is scheduled to report its fourth quarter 2012 results on Feb 1, 2013 before the opening ...
-
January 30, 2013
Better-than-expected quarterly results once again guided the S&P 500 and the Dow Jones into the green on Tuesday. ...
-
January 29, 2013
We are in the midst of the fourth quarter earnings season and it is once again time to review the players in the ...
-
January 29, 2013
We are in the midst of the fourth quarter earnings season and it is once again time to review the players in the ...
-
January 28, 2013
Dr. Reddy's Laboratories (RDY) recently announced the launch of its generic version of Merck & Co's (MRK) Singulair ...
-
January 28, 2013
Merck (MRK) recently announced that it has received US Food and Drug Administration (FDA) approval for its ...
-
January 23, 2013
Pfizer filed further details about its tentative spin-off of Zoetis, its animal health business.
-
January 22, 2013
Johnson & Johnson's (JNJ) fourth quarter 2012 earnings (excluding special items) of $1.19 per share were a couple of ...
